Factors | Univariate | ||
---|---|---|---|
Hazard ratio | 95% confidence interval | P value | |
Gender = male | 1.46 | 0.65–3.24 | 0.356 |
Age (year) | 1.02 | 1–1.05 | 0.078 |
BMI | 1.03 | 0.94–1.13 | 0.550 |
MBP (mmHg) | 1.02 | 1–1.03 | 0.035 |
Serum creatinine (μmol/L) | 1 | 1–1.01 | 0.224 |
eGFR | 0.99 | 0.98–1 | 0.062 |
Serum albumin (g/L) | 1 | 0.96–1.04 | 0.874 |
WBC count (10^9/L) | 1.02 | 0.93–1.11 | 0.679 |
Hemoglobin (g/L) | 0.99 | 0.98–1 | 0.191 |
Platelet (10^9/L) | 1 | 1–1 | 0.722 |
Proteinuria (g/24 h) | 1.02 | 0.93–1.13 | 0.664 |
Urinary albumin/creatinine ratio (mg/μmol) | 1.41 | 0.81–2.46 | 0.229 |
Urine WBC (/HP) | 1.02 | 1–1.04 | 0.087 |
Urine RBC (/HP) | 1 | 1–1 | 0.951 |
C3 (g/L) | 0.82 | 0.25–2.7 | 0.739 |
C4 (g/L) | 0.14 | 0–9.59 | 0.358 |
Positive ANA | 2.24 | 1.41–3.55 | < 0.001 |
Positive anti-dsDNA | 2.06 | 1.39–3.05 | < 0.001 |
SLEDAI | 1.03 | 1–1.07 | 0.082 |
Modified NIH index | |||
AI | 1.07 | 1.01–1.15 | 0.034 |
CI | 1.22 | 1.1–1.34 | < 0.001 |
Crescent | |||
Non-crescent | refer | ||
Crescent | 1.74 | 1.18–2.57 | 0.006 |
Treatment | |||
Steroid dosage (g) | 1.04 | 1.02–1.07 | 0.001 |
Proportion of pulse (g) | 1.29 | 0.51–3.24 | 0.587 |
Pulse dosage (g) | 0.95 | 0.47–1.92 | 0.878 |
CTX dosage (g) | 1.05 | 0.97–1.14 | 0.229 |